Ferhina Ali Last Word

Related

• 

  Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections

  Geoffrey G. Emerson, MD, PhD, FASRS

  Updates from the Field

  2021

• 

  Novel Vascular Endothelial Growth-Factor A (VEGF-A) and Angiopoietin-2 (Ang-2) Bispecific Protein, RO-634, in Comparison to Aflibercept

  Mark R. Barakat, MD

  Annual Meeting Talks

  2022

• 

  Episode 22: Stroke Risk in Patients with CRAO with Dr. Matthew Schrag

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2019